Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for RMH Holdings Limited (8437:TWSE), powered by AI.
RMH Holdings Limited is currently trading at $10.55. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for RMH Holdings Limited on Alpha Lenz.
View RMH Holdings Limited's valuation metrics on Alpha Lenz.
“RMH Holdings Limited's ROE is -2.5%. Explore profitability and growth together.”
Ask for details →RMH Holdings Limited is a healthcare services company specializing in the delivery of medical, dermatological, and aesthetic care through a network of clinics across Singapore and Hong Kong. The group operates multiple centers, including dermatology and surgery clinics, an aesthetic and laser center, a multi-specialists center, and a regenerative medicine facility. Its core offerings encompass the medical, surgical, and laser treatment of a wide range of dermatological conditions affecting the skin, hair, and nails, with a noted emphasis on skin cancer surveillance and specialized procedures such as Mohs Micrographic Surgery. RMH Holdings Limited also provides a range of aesthetic medicine services and offers proprietary skin care and anti-aging products, reflecting its diversified approach within the health and wellness sector. The company primarily serves patients seeking both clinical and aesthetic improvements, while contributing to advancements in dermatological care and skin health management. As a listed entity, RMH Holdings Limited plays a significant role within the Southeast Asia healthcare landscape, supporting sector growth through its clinical expertise, expanding service lines, and ongoing investment in healthcare innovation.
“RMH Holdings Limited's ROE is -2.5%. Explore profitability and growth together.”
Ask for details →RMH Holdings Limited (ticker: 8437) is a company listed on TWSE in the Consumer Defensive sector (Education & Training Services).
The current price is 10.55 with a P/E ratio of -x and P/B of -x.
ROE is -2.53% and operating margin is -47.00%. Annual revenue is $215M.